Attempt to disqualify Baker Botts denied
A federal judge has denied Takeda Pharmaceuticals’ request that Baker Botts be disqualified from representing Zydus Pharmaceuticals in antitrust litigation against Takeda.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10